Enhancement of interleukin-12 gene-based tumor immunotherapy by the reduced secretion of p40 subunit and the combination with farnesyltransferase inhibitor.

Source:http://linkedlifedata.com/resource/pubmed/id/15812228

Download in:

View as

General Info

PMID
15812228